Physician profile
Keith H Newby
NPI 1609809623
$89,976.05
in general payments reported to CMS, 2019-2025
33 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $27K · 2021: $464 · 2022: $177 · 2023: $1,926 · 2024: $30K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $60K · Travel and Lodging: $1,140 · Food and Beverage: $1,057 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $60,000.00 |
| Travel and Lodging | $1,139.91 |
| Food and Beverage | $1,056.66 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $86,020.46 | 2020-2025 | Mcot, (5044) Mcot, Extended Holter |
| Medtronic, INC. | $1,388.02 | 2023 | Azure Xt Dr Mri Surescan, Selectsecure |
| Amgen INC. | $354.44 | 2019-2023 | Repatha |
| Scpharmaceuticals INC. | $293.34 | 2023-2025 | |
| Arbor Pharmaceuticals, INC. | $230.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $215.87 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $165.46 | 2019-2025 | Lokelma, Farxiga |
| Cvrx, INC. | $159.09 | 2023 | Barostim Neo System |
| Bardy Diagnostics, INC. | $114.19 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.75 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $107.61 | 2019-2021 | |
| Astellas Pharma US INC | $103.57 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $87.65 | 2019-2023 | |
| Boston Scientific Corporation | $77.07 | 2020-2023 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Sanofi-Aventis U.S. LLC | $75.43 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $54.76 | 2024-2025 | Vitalpatch Rtm |
| Baxter Healthcare | $53.43 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, Ltd. | $40.16 | 2021-2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $33.81 | 2021-2022 | |
| Medicomp INC | $32.99 | 2023 | Telepatch Cardiac Monitor |
| Amarin Pharma, INC. | $32.81 | 2019-2020 | |
| Pfizer INC. | $29.79 | 2021-2023 | |
| Novo Nordisk INC | $27.87 | 2020 | |
| Braemar Manufacturing, LLC | $21.40 | 2019 | |
| Abbvie INC. | $20.62 | 2021 | |
| Akcea Therapeutics, INC. | $19.58 | 2020 | |
| Preventice Services, LLC | $18.78 | 2021 | |
| Gilead Sciences, INC. | $18.00 | 2019 | |
| Vifor Pharma, INC. | $16.48 | 2020 | |
| Allergan, INC. | $14.70 | 2019 | |
| Lundbeck LLC | $13.74 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.37 | 2019 | |
| Esperion Therapeutics, INC. | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Newby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.